Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

12 Jun 2020 09:58

RNS Number : 8176P
Catenae Innovation PLC
12 June 2020
 

12 June 2020

 

Catenae Innovation PLC

 

("Catenae", or the "Company")

 

Issue of Equity

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, today announces that it has issued 37,500,000 new ordinary shares at a price of 2p per share ("Placing").

 

35,150,000 new ordinary shares have been issued for cash, providing the Company with proceeds of £703,000, a further 2,350,000 new ordinary shares have been issued to settle liabilities of £47,000.

 

The Placing has been conducted through Brandon Hill Capital Limited, the Company's broker.

 

The proceeds of the Placing will provide the Company with additional working capital headroom to progress its activities.

 

Application will be made to the London Stock Exchange to admit the 37,500,000 new ordinary shares to trading on AIM. Admission of the new ordinary shares is expected to occur on or around 18 June 2020. The new ordinary shares will rank pari passu with the existing ordinary shares.

 

For the purpose of the Disclosure and Transparency Rules, following the issue of shares detailed above the enlarged issued share capital of the Company will comprise 203,410,407 ordinary shares of 0.2p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

 

Guy Meyer, Interim Chief Executive Officer of Catenae, said: 

"I would like to take this opportunity to thank existing investors for their support of the Company and to welcome the new shareholders who have joined Catenae.

 

"The fundraising underpins the Board's strategy to strengthen the balance sheet and provide the Company with the resource to execute on our plans.

 

"The Board is excited by the Company's prospects and looks forward to creating long-term value for all our stakeholders."

 

- Ends -

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Interim CEO

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

 

 

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

+44 (0)78796 8313

Yellow Jersey PR (PR & IP)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins

 

 

Forward-Looking Statements

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

 

The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOESFLSAEESSEIM
Date   Source Headline
30th Mar 20213:42 pmRNSDirector dealings
30th Mar 20217:00 amRNSUK Government 'COVID-Status Certification Review'
29th Mar 20217:00 amRNSAnnual Report and Accounts, Trading Update
16th Mar 20211:19 pmRNSExercise of Warrant
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:13 pmRNSHolding(s) in Company
26th Feb 202111:00 amRNSCorrection re Placing, Conversions, Warrants
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20217:00 amRNSDigital Identity Policy Consultation
29th Jan 20217:00 amRNSPilot Agreement
27th Jan 20217:00 amRNSPlacing, Conversions, Warrants & Business Update
11th Jan 20212:06 pmRNSSecond Price Monitoring Extn
11th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Dec 202011:39 amRNSHolding(s) in Company
15th Dec 20203:41 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBusiness Update
9th Dec 20209:27 amRNSHolding(s) in Company
5th Nov 202012:30 pmRNSUpdate on Afrik-ID
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
2nd Nov 202011:06 amRNSSecond Price Monitoring Extn
2nd Nov 202011:00 amRNSPrice Monitoring Extension
16th Oct 20208:43 amRNSIssue of Warrants
16th Oct 20207:00 amRNSJoint Venture with Blackhive Africa Medical
25th Sep 202012:26 pmRNSResult of AGM
4th Sep 202012:50 pmRNSPosting of Notice of AGM
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
25th Aug 20207:00 amRNSBusiness Update
24th Aug 20207:00 amRNSCreditor Share Conversion and Notice of AGM
19th Aug 20202:32 pmRNSHolding(s) in Company
23rd Jul 202011:05 amRNSSecond Price Monitoring Extn
23rd Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSChange of Director Role and Grant of Options
17th Jul 20207:00 amRNSTransfer and Exercise of Warrants
9th Jul 202011:05 amRNSSecond Price Monitoring Extn
9th Jul 202011:00 amRNSPrice Monitoring Extension
8th Jul 20209:14 amRNSHolding(s) in Company
6th Jul 20202:06 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 20201:15 pmRNSExercise of Warrants
6th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20207:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSCompletion of New Product - Onsite ID
3rd Jul 20207:00 amRNSCommercial Pilot Agreement with Afrik-ID
2nd Jul 20208:01 amRNSHolding(s) in Company
1st Jul 20203:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.